Preclinical IND Project Lead

RedFox Therapeutics is an emerging biotech dedicated to developing first-in-class drugs for underserved diseases. Our lead pipeline candidate is a preclinical-stage small molecule, for an orphan cornea condition without any FDA-approved therapies. Role OverviewThe Preclinical IND Project Manager will be responsible for driving execution across RedFox’s R&D programs and ensuring operational excellence. This individual will manage project timelines and deliverables, oversee CROs and external partners, and work closely with our Chief Scientific and Medical Officer, a former Pharma C-suite executive, to advance our pipeline. A key responsibility will be oversight of IND‑enabling studies (pharmacology, pharmacokinetics, toxicology & CMC).This is a unique opportunity for a highly motivated professional to grow with RedFox and assume increasing leadership responsibilities as the company scales.Key ResponsibilitiesProject Management·        Lead planning and execution of IND‑enabling studies, including pharmacology, toxicology, CMC, and related regulatory deliverables.·        Manage project timelines, risk assessments, and deliverable tracking, in collaboration with the Chief Scientific & Medical Officer·        Ensure achievement of key scientific and operational milestones with high quality standards.CRO & External Partner Oversight·        Manage relationships with CROs, consultants, and other external vendors.·        Ensure quality, compliance, and timely delivery of outsourced work.·        Support preclinical study design, data interpretation and decision-makingMiscellaneous·        Support business development activities, including partnership outreach and market research.·        Support operational processes to ensure smooth execution of R&D and corporate activitiesRequired Qualifications·        Master’s degree in life sciences, chemistry or a related field; PhD or MD is a plus.·        3 – 5 years of experience in biotech, pharma, or healthcare consulting, with exposure to project management·        Experience with IND‑enabling studies (pharmacology, toxicology, CMC, or regulatory submissions).·        Experience with sustained release formulation is a plusWhat We Offer·        Compensation & Equity: Strong base compensation plus equity with real upside. You’ll be joining early—and we believe early builders should be rewarded with ownership. ·        Career and Personal Growth: Opportunity to work closely with former C-suite Pharma executives and gain exposure to all aspects of company building.·        Mission Driven Environment: Your contributions will positively impact patient lives.  Location: Singapore or Global. Employment Full-time. To start in Jan or Feb 2026.To apply: On LinkedIn or send CVs to danielwong at redfox-tx dot com